Should Medicare provide reimbursement for prostate-specific antigen testing for early detection of prostate cancer? Part I: Framing the debate.
Barry
M J
MJ
Medical Practices Evaluation Center, Massachusetts General Hospital, Boston 02114, USA.
Fleming
C
C
Coley
C M
CM
Wasson
J H
JH
Fahs
M C
MC
Oesterling
J E
JE
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D006801:Humans; D008017:Life Expectancy; D008297:Male; D008403:Mass Screening / Q000191:economics*; D006278:Medicare / Q000191:economics*; D008875:Middle Aged; D009367:Neoplasm Staging; D017430:Prostate-Specific Antigen / Q000032:analysis*; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy; D016032:Randomized Controlled Trials as Topic; D012051:Reimbursement Mechanisms; D015996:Survival Rate; D014481:United States / Q000453:epidemiology
D017430:Prostate-Specific Antigen